United Therapeutics Corp (STU:UTH)
€ 251 -5 (-1.95%) Market Cap: 11.20 Bil Enterprise Value: 9.25 Bil PE Ratio: 12.90 PB Ratio: 2.26 GF Score: 87/100

United Therapeutics Corp at Wedbush PacGrow Healthcare Conference (Virtual) Transcript

Aug 11, 2021 / 12:35PM GMT
Release Date Price: €174 (-1.14%)
Andreas Argyrides
Wedbush Securities Inc., Research Division - Analyst

Good morning, everyone, and welcome to the Wedbush PacGrow 2021 Virtual Healthcare Conference. Thanks for joining us. My name is Andreas Argyrides, and I'm one of the health care analysts at Wedbush, alongside Liana Moussatos.

It's my pleasure to introduce our next presenting company, United Therapeutics. Today, we are joined by the CEO, Martine Rothblatt; Chief Financial Officer, James Edgemond; and Head of IR, Dewey Steadman. Thanks very much for joining us.

We will start with a fireside chat and transition to Q&A. (Operator Instructions)

Dewey, do you have any opening remarks?

Dewey Steadman;
United Therapeutics Corporation - Head of IR

Yes. Thank you, Andreas. Good morning. Our remarks today may include forward-looking information about our business. And please see our SEC filings, especially Forms 10-K and 10-Q, for risks and uncertainties that could cause actual results to differ.

With that, I'll turn it back over to you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot